focus -WSS

focus

author：entertainment 2025-09-29 18:16:52 - browse：9423

Aduhelm package — Jessica Rinaldi/The Boston Globe

Biogen is giving up its ownership of Aduhelm, the Alzheimer’s disease treatment whose 2021 approval led to scrutiny and outrage, turning the page on a tempestuous chapter in the company’s long history.

Neurimmune, the Swiss company that invented Aduhelm, will regain full rights to the intravenous medicine, Biogen said Wednesday. Biogen will also terminate an ongoing clinical trial meant to prove the treatment’s benefits for patients in the early stages of Alzheimer’s.

“When searching for new medicines, one breakthrough can be the foundation that triggers future medicines to be developed,” Biogen CEO Christopher Viehbacher said in a statement. “Aduhelm was that groundbreaking discovery that paved the way for a new class of drugs and reinvigorated investments in the field.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： What it’s like to watch children die of measles

WSS

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

How a key Senate committee is planning to regulate PBMs

Doctors have an ethical obligation to be advocates

Sophia Smith scores twice for US in in 3

Severe heat forecast: Where scorching temperatures will persist over the next week

FDA approves first blood sugar monitor without finger pricks

focus

focus

Wikipedia

23andMe had bad news about my health. I wish a person had delivered it

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Hollywood unions extend contract negotiations for actors

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Trump demands the U.S. pay no more for drugs than other countries … again

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Cancer drug shortages should be causing more outrage

How a key Senate committee is planning to regulate PBMs

What does generative AI mean for health care? We asked experts

Air quality improving but still lags in Black, Hispanic communities

Wikipedia

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Change Healthcare payments predicted restored March 15

CDC marks new Covid

Headspace, Meta partner to launch VR meditation app for Quest

focus

explore

focus

hotspot